The partners will study patient-focused endpoints alongside so-called “hard outcomes" that have traditionally served as endpoints in clinical trials.
Elon Musk pulled back the curtain on his brain interface-developing Neuralink, saying the startup holds the promise of merging people with AI.
Paragon Biosciences built a new portfolio company around its acquisition of the first FDA-cleared AI system for diagnosing breast cancer.
GNS Healthcare raised $23 million from the VC arms of drugmakers and health insurers to build out its AI-driven precision medicine platform.
Notable Labs is adding $40 million to its reserves as it scales up its capabilities with plans to take its platform worldwide.
The FDA approved Bayer’s Gadavist MRI contrast agent to help gauge the blood supply of the heart muscle.
Machine learning-powered drug discoverer Recursion Pharmaceuticals has secured $121 million in new financing for its artificial intelligence programs.
GE Healthcare recalled two of its infant warmers due to side panels and latches that may crack, break or open, allowing infants to fall.
Abbott received FDA approval for an addition to its Alinity line of diagnostic hardware designed to screen blood and plasma donations.
Hot on the heels of an international distribution deal with Terumo, Orchestra BioMed has secured $34 million in new funding for its devices.
